Skip to content

Field Shape and Amplitude Sensitivity Exploratory Study (CONTOUR Study)

TerminatedNot applicableNCT02916498
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The study aims to better understand how to program Spinal Cord Stimulation for the treatment of chronic low back and leg pain

Study details

Official title
Field Shape and Amplitude Sensitivity Exploratory Study (CONTOUR Study)
Conditions
  • Chronic Neuropathic Pain in the Low Back and Legs
Interventions
  • Device: Boston Scientific's Precision SPECTRA™ Spinal Cord Stimulation System
Sponsor
Boston Scientific Corporation
Start date
2017-02-07
Primary completion
2018-07-23
Sex
All
Age range
from 18 Years
Results posted
Yes, on ClinicalTrials.gov
Countries
United Kingdom
Total sites listed
2

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Key Inclusion Criteria: * Documented average low back pain intensity of at least 6 out of 10 and greater or equal than average leg pain intensity over 7 days during screening (Numerical Rating Scale) * Stable daily pain-related medication prescription and intake of ≤100mg morphine-equivalents * Capacity to describe and rate pain intensity, complete study measurements, and use the study device (e.g. patient remote control, charger, diary ratings) (physician discretion) Key Exclusion Criteria: * Presence of pain or psychological condition that in the opinion of the investigator may interfere with the subject's ability to rate their pain and communicate such ratings * Previous Spinal Cord Stimulation trial or is already implanted with an active implantable device(s) (e.g. pacemaker, drug pump, implantable pulse generator)

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02916498